Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus

European Journal of Clinical Investigation, Supplement

Volumn 28, Issue 2, 1998, Pages 8-13

  Nijpels, G ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Impaired glucose tolerance; Insulin resistance; Non insulin dependent diabetes mellitus; Progression

Indexed keywords

PROINSULIN;

BODY MASS; CARDIOVASCULAR RISK; CONFERENCE PAPER; GLUCOSE INTOLERANCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 0031716242     PISSN: 0960135X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.0280s2008.x     Document Type: Conference Paper

References (48)

1. WHO Expert Committee on Diabetes Mellitus. Second Report: Technical Reports Series 646. Geneva: World Health Organization 1980.
2. '2 WHO Diabetes Mellitus: Report on a WHO Study Group. Technical Reports Series 727. Geneva: World Health Organization 1985.
3. Modan M, Harris MI, Halkin H. Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Diabetes 1989; 38: 1630-5.
4. Keen K, Jarrett RJ, McCartney P. The ten-year follow-up of the Bedford Survey (1962-72): glucose tolerance and diabetes. Diabetologia 1982; 22: 73-8.
5. Jarrett RJ, Keen H, McCartney P. The Whitehall Study: ten year follow-up report on men with impaired glucose tolerance with reference to worsening of diabetes and predictors of death. Diabet Med 1984; 1: 279-83.
6. Sartor G, Scherstén B, Carlström S et al. Ten-year follow-up of subjects with impaired glucose tolerance. Diabetes 1988; 29: 41-9.
7. Knowler WC, Pettitt DJ, Everhart JE, Slaine KS, Bennett PH, Mott D. Rate of deterioration of impaired glucose tolerance to diabetes and the effect of age, obesity and serum insulin. Diabetologia 1986; 29: A558.
8. Frenck LR, Boen JR, Martinez AM, Bushhouse SA, Sprafka JM, Goetz FC. Population based study of impaired glucose tolerance and type 2 diabetes in Wadena, Minnesota. Diabetes 1990; 39: 1131-7.
9. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic review. Diabetes Metab Rev 1987; 3: 468-525.
10. Pyorala K, Savolainen E, Lehtovirta E, Punsar S, Siltanen P. Glucose tolerance and coronary heart disease: Helsinki policemen study. J Chron Dis 1979; 32: 729-45.
11. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. JAMA 1990; 263: 2893-8.
12. Merrin PK, Feher MD, Elkeles RS. Diabetic macrovascular disease and serum lipids: is there a connection? Diabet Med 1992; 9: 9-14.
13. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
14. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance sydrome (Syndrome X). Diabetes 1992; 41: 715-22.
15. Reaven GM. The fourth musketeer-from Alexander Dumas to Claude Bernard. Diabetologia 1995; 38: 3-13.
16. Harris MI, Hadden WC, Knowler WC, Bennett PH. International criteria for the diagnosis of diabetes and impaired glucose tolerance. Diabetes Care 1985; 8: 562-7.
17. Harris MI. Impaired glucose tolerance in the U.S. population. Diabetes Care 1989; 12: 464-74.
18. Mooy JM, Grootenhuis PA, de Vries H et al. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population: the Hoorn Study. Diabetes Care 1995; 18: 1270-3.
19. Ward WK, Beard JC, Porte D. Islet β-cell function in human subjects. In: Methods in Diabetes Research, Vol II. Clinical Methods. Wiley Interscience; 1986: 4-12.
20. Cerasi E, Kesher R. Assessment of insulin secretion dynamics. In: Methods in Diabetes Research, Vol II. Clinical Methods. Wiley Interscience; 1986: 77-85.
21. Haeften van TW. Stimulation by arginine and hyperglycemic glucose clamp. Academisch proefschrift Vrije Universiteit Amsterdam 1990; 75-84: 113-28.
22. Rudenski AS, Hosker JP, Burnett MA, Matthews DR, Turner RC. The beta cell glucose stimulus response curve in normal humans assessed by insulin and C-peptide secretion rates. Metabolism 1988; 237: 526-34.
23. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-23.
24. Porte D. β cells in type II diabetes mellitus. Diabetes 1991; 40: 166-80.
25. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocrine Rev 1985; 6: 45-86.
26. DeFronzo R, Ferrannini E. Insulin resistance. Diabetes Care 1991; 14: 173-94.
27. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
28. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959-65.
29. Nijpels G, van der Wal PS, Bouter LM, Heine RJ. Comparison of three methods for the quantification of β-cell function and insulin sensitivity. Diab Res Clin Pract 1994; 26: 189-95.
30. Saad MF, Knowler WC, Pettitt DJ et al. A two-step model for development of non-insulin-dependent diabetes. Am J Med 1991; 90: 229-35.
31. Lillioja S, Mott DM, Spraul M et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 1988-92.
32. Hanson RL, Narayan KM, McCance DR et al. Rate of weight gain, weight fluctuation, and incidence of NIDDM. Diabetes 1995; 44: 261-6.
33. Nagi DK, Knowler WC, Charles MA et al. Early and late insulin response as predictors of NIDDM in Pima Indians with impaired glucose tolerance. Diabetologia 1995; 38: 187-92.
34. Zimmet PZ, Collins VR, Dowse GK, Knight LT. Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 534-41.
35. Sicree RA, Zimmet PZ, King HOM, Coventry JS. Plasma insulin response among Nauruans. Diabetes 1987; 3679-86.
36. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity and body fat distribution. Diabetes 1990; 39: 104-11.
37. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance, the Hoorn Study. Diabetologia 1996; 39: 113-8.
38. Motala AA, Omar MAK, Gouws E. High risk of progression to NIDDM in South African Indians with impaired glucose tolerance. Diabetes 1993; 42: 555-63.
39. Skarfors ET, Selinus KL, Lithell HO. Risk factors for developing non-insulin dependent diabetes: a ten year follow-up of men in Uppsala. Br Med J 1991; 303: 755-60.
40. Lundgren H, Bengtsson C, Blohmé G, Lapidus L, Waldenström J. Fasting insulin and early insulin response as risk determinants for developing diabetes. Diabetic Med 1990; 7: 407-13.
41. Ohlson L-O, Larsson B, Björntorp P et al. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 1988; 31: 798-805.
42. Kadowaki T, Miyake Y, Hagura R et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 1984; 26: 44-9.
43. Austin MA, Mykkänen L, Kuusisto J et al. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 1995; 92: 1770-8.
44. Mykkänen L, Kuusisto J, Pyöräla K, Laakso M, Haffner SM. Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects. J Hypertens 1994; 12: 1425-32.
45. Narayan KM, Hanson RL, Pettitt DJ, Bennett PH, Knowler WC. A two-step strategy for identification of high-risk subjects for a clinical trial for prevention of NIDDM. Diabetes Care 1996; 19: 972-8.
46. Grootenhuis PA, Mooy JM, Vries de H, Bouter LM, Heine RJ. Cardiovascular risk factors in relation to various degrees of glucose intolerance and insulinaemia in a general Caucasian population. PhD Thesis, Vrije Universiteit Amsterdam, Amsterdam 1994.
47. Alberti KGMM, Gries FA. Management of non-insulin-dependent diabetes mellitus in Europe: a consensus view. Diabetic Med 1988; 5: 275-82.
48. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ. Cardiovascular risk factors prior to the conversion from IGT to NIDDM, the Hoorn Study. J Clin Epid 1997; 50: 1003-9.